# Determination of the Optimal Treatment Target in Ulcerative Colitis

> **NCT04259138** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Alimentiv Inc.** · enrollment: 672 (actual)

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **BIOLOGICAL:** Treatment Algorithm A
- **BIOLOGICAL:** Treatment Algorithm B
- **BIOLOGICAL:** Treatment Algorithm C

## Key facts

- **NCT ID:** NCT04259138
- **Lead sponsor:** Alimentiv Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-02-18
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 672 (ACTUAL)
- **Last updated:** 2026-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04259138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04259138, "Determination of the Optimal Treatment Target in Ulcerative Colitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04259138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*